April 04, 2024 – Mississauga, Ontario. CPL, a leading contract development and manufacturing organization (CDMO) of non-sterile liquid and topical drug products, recently completed a successful inspection of its Mississauga production facility by Health Canada.
Health Canada performed a routine inspection of CPL’s Danbro facility which includes the GMP manufacturing, packaging, and warehousing areas. Following the inspection, CPL received a Compliant rating.
CPL’s Senior Director of Quality, Martin Tulinski, states: “We are pleased with the favorable outcome of the inspection, which underscores our commitment to excellence. Our dedication to continuous improvement drives us to embrace each inspection as an opportunity to enhance our processes and elevate our standards even further.”
About CPL
CPL is a leading contract development and manufacturing organization (CDMO) that provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical prescription and regulated OTC products.